DLD Asset Management LP Has $3.58 Million Stake in Oaktree Acquisition Corp. III Life Sciences $OACC

Key Points

• DLD Asset Management LP increased its stake in Oaktree Acquisition Corp. III Life Sciences (OACC) by 100%, owning 350,000 shares worth approximately $3.58 million as of its latest SEC filing.
• Several other hedge funds have also entered into positions in OACC during the first quarter, with new stakes purchased by firms such as Kepos Capital LP and Mizuho Securities USA LLC, totaling over $4 million in investments.
• The company's share price opened at $10.49 and has fluctuated between a 52-week low of $9.95 and a high of $10.85.

DLD Asset Management LP increased its position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) by 100.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 350,000 shares of the company's stock after purchasing an additional 175,000 shares during the quarter. DLD Asset Management LP owned 1.56% of Oaktree Acquisition Corp. III Life Sciences worth $3,580,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. HighTower Advisors LLC acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth approximately $1,401,000. Picton Mahoney Asset Management acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at $767,000. Ghisallo Capital Management LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at $4,590,000. Kepos Capital LP acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth $563,000. Finally, Linden Advisors LP bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth $6,120,000.

Oaktree Acquisition Corp. III Life Sciences Stock Performance

NASDAQ OACC remained flat at $10.49 during trading on Monday. The company's stock had a trading volume of 882 shares, compared to its average volume of 102,235. Oaktree Acquisition Corp. III Life Sciences has a 12-month low of $9.95 and a 12-month high of $10.85. The firm's fifty day moving average price is $10.44 and its 200 day moving average price is $10.36.

Oaktree Acquisition Corp. III Life Sciences Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.